In my opinion with 2591 being a potential platform drug capable of treating multiple indications Big Pharma would have a heightened interest in owning rather than licencing it. That way they could have total control over it's future direction and value.
Share Price, page-12230
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.29 |
Change
-0.325(2.39%) |
Mkt cap ! $1.705B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.20 | $4.967M | 371.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 316 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.29 | 1551 | 9 |
View Market Depth
| Last trade - 14.04pm 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |